ZA99874B - Organic compounds. - Google Patents

Organic compounds.

Info

Publication number
ZA99874B
ZA99874B ZA9900874A ZA99874A ZA99874B ZA 99874 B ZA99874 B ZA 99874B ZA 9900874 A ZA9900874 A ZA 9900874A ZA 99874 A ZA99874 A ZA 99874A ZA 99874 B ZA99874 B ZA 99874B
Authority
ZA
South Africa
Prior art keywords
organic compounds
epothilone
administration
methods
pharmaceutical formulations
Prior art date
Application number
ZA9900874A
Other languages
English (en)
Inventor
Peter Van Hoogevest
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10826504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA99874(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA99874B publication Critical patent/ZA99874B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9900874A 1998-02-05 1999-02-04 Organic compounds. ZA99874B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9802451.6A GB9802451D0 (en) 1998-02-05 1998-02-05 Organic compounds

Publications (1)

Publication Number Publication Date
ZA99874B true ZA99874B (en) 1999-08-05

Family

ID=10826504

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9900874A ZA99874B (en) 1998-02-05 1999-02-04 Organic compounds.

Country Status (9)

Country Link
EP (1) EP1800664B8 (el)
AT (1) ATE427736T1 (el)
CY (1) CY1109190T1 (el)
DE (1) DE69940708D1 (el)
DK (1) DK1800664T3 (el)
ES (1) ES2324376T3 (el)
GB (1) GB9802451D0 (el)
PT (1) PT1800664E (el)
ZA (1) ZA99874B (el)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
ES2206607T3 (es) * 1995-11-17 2004-05-16 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Derivados de epotilones, preparacion y utilizacion.
WO1997033552A1 (en) * 1996-03-12 1997-09-18 Pg-Txl Company, L.P. Water soluble paclitaxel prodrugs
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
TW457095B (en) * 1998-02-05 2001-10-01 Novartis Ag Pharmaceutical formulations comprising epothilones and lyophilised compositions comprising epothilones

Also Published As

Publication number Publication date
ES2324376T3 (es) 2009-08-05
CY1109190T1 (el) 2014-07-02
DE69940708D1 (de) 2009-05-20
GB9802451D0 (en) 1998-04-01
EP1800664B8 (en) 2010-12-15
ATE427736T1 (de) 2009-04-15
EP1800664A1 (en) 2007-06-27
DK1800664T3 (da) 2009-07-20
EP1800664B1 (en) 2009-04-08
PT1800664E (pt) 2009-07-10

Similar Documents

Publication Publication Date Title
MY125921A (en) Compositions containing organic compounds
IL144501A0 (en) Epothilone derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
WO2000007979A3 (en) Compounds and compositions for delivering active agents
IL231675A (en) Concentrated protein compositions with reduced viscosity
GEP20053473B (en) High Potency Dihydroergotamine Compositions
AU2001241423A1 (en) Needleless syringe
CA2338358A1 (en) Compounds and compositions for delivering active agents
GEP20043203B (en) EP4 Receptor Selective Agonists in the Treatment of Osteoporosis
AU2001237485A1 (en) Needleless syringe with two injection speed levels
MXPA03002070A (es) Proceso de anticoncepcion y forma de administracion para el mismo.
IL148870A (en) 2'-substituted 1,1'-biphenyl - 2 - carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
EP0683668A4 (en) PREPARATIONS AND METHODS FOR TRANSDERMAL DRUG ADMINISTRATION.
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
GB9802451D0 (en) Organic compounds
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
WO2000017366A3 (en) Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
AU1556601A (en) 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
ECSP992852A (es) Compuestos organicos
AU8028600A (en) Methods, pharmaceutical and therapeutic compositions for administering adenosine
HUP0202594A3 (en) Streptogramin derivatives, production thereof and pharmaceutical compositions containing the same
AU2001270903A1 (en) Needleless syringe
AU3278400A (en) New use of taxoid derivatives
HK1105808A1 (en) Pharmaceutical formulations for parenteral administration comprising epothilone